Learn About Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency

What is the definition of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency?

Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a rare condition that prevents the body from converting certain fats to energy, particularly during periods without food (fasting).

Save information for later
Sign Up
What are the causes of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency?

Mutations in the HADHA gene cause LCHAD deficiency. The HADHA gene provides instructions for making part of an enzyme complex called mitochondrial trifunctional protein. This enzyme complex functions in mitochondria, the energy-producing centers within cells. As the name suggests, mitochondrial trifunctional protein contains three enzymes that each perform a different function. This enzyme complex is required to break down (metabolize) a group of fats called long-chain fatty acids. Long-chain fatty acids are found in foods such as milk and certain oils. These fatty acids are stored in the body's fat tissues. Fatty acids are a major source of energy for the heart and muscles. During periods of fasting, fatty acids are also an important energy source for the liver and other tissues.

How prevalent is Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency?

The incidence of LCHAD deficiency is unknown. One estimate, based on a Finnish population, indicates that 1 in 62,000 pregnancies is affected by this disorder. In the United States, the incidence is probably much lower.

Is Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Local Doctors?
Elite
Highly rated in
3
conditions

Karolinska Institutet

Stockholm, AB, SE 

Charlotte Haglind is in Stockholm, Sweden. Haglind is rated as an Elite expert by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. She is also highly rated in 3 other conditions, according to our data. Her top areas of expertise are Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Mitochondrial Trifunctional Protein Deficiency, Protein Deficiency, and Rhabdomyolysis.

Distinguished
Highly rated in
11
conditions

Universidade Federal Do Rio Grande Do Sul

Porto Alegre, RS, BR 

Cristiane Cecatto is in Porto Alegre, Brazil. Cecatto is rated as a Distinguished expert by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. They are also highly rated in 11 other conditions, according to our data. Their top areas of expertise are Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Mitochondrial Trifunctional Protein Deficiency, Pyruvate Carboxylase Deficiency, and Very Long-Chain Acyl-Coa Dehydrogenase Deficiency.

 
 
 
 
Learn about our expert tiers
Learn more
Distinguished
Highly rated in
19
conditions

Medical University Of Innsbruck

Innsbruck, AT 6020

Daniela Karall is in Innsbruck, Austria. Karall is rated as a Distinguished expert by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. She is also highly rated in 19 other conditions, according to our data. Her top areas of expertise are Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Propionic Acidemia, Inborn Amino Acid Metabolism Disorder, and Mitochondrial Trifunctional Protein Deficiency.

What are the latest Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Clinical Trials?
Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program (LC-FAOD DMP)
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date:updated Last, May

Published By: National Institutes of Health

What are the Latest Advances for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency?

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.